Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-2045-01
Published December 5, 2012 · Recall initiated: June 29, 2012
Summary
FDA records drug Class II recall D-066-2013, published December 5, 2012 and initiated June 29, 2012. Recalling firm: Mylan LLC.; Status: Terminated; Reported quantity: 15181 bottles.; Lot: Lots: 3027684 Exp. 5/13, 3027688 Exp. 6/13 2002157 Exp. 9/12. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed USP Content Uniformity Requirements: OOS result reported on retained samples.
What to do
Voluntary: Firm initiated · Letter
Get an email if TACROLIMUS has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- TACROLIMUS
- Manufacturer
- Mylan LLC.
- Distributor
- Natiowide
- UPC
- 0303782046014
- Lot
- Lots: 3027684 Exp. 5/13, 3027688 Exp. 6/13 2002157 Exp. 9/12
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited,January 17, 2024
- FDATacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's Laboratories Limited,March 1, 2023
- FDATacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDCAugust 10, 2022
- FDATacrolimus Capsules, USP 5mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, NDCApril 1, 2020
- FDAAdvair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDCDecember 5, 2012
- FDAPradaxa (dabigatran etexilate), 75 mg Capsules, 60 count bottles, Rx only, Distributed by Boehringer IngelheimDecember 5, 2012
Questions about this recall
Was Mylan, Tacrolimus Capsules 0.5 mg, 100 count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-2045-01 recalled?
Yes. FDA published recall D-066-2013 on December 5, 2012. Reported hazard: Failed USP Content Uniformity Requirements: OOS result reported on retained samples.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: TACROLIMUS. UPC: 0303782046014.